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Statement of clinical relevance 
The use of mesenchymal stem cells (MSCs) for tissue engineering and regenerative 
medicine applications is attractive, in part due to their ability to differentiate into multiple cell 
types and their ease of expansion in vitro. MSC growth and differentiation are influenced by 
the extracellular environment, which is sensed by integrin cell-surface receptors binding to 
extracellular matrix (ECM) components. This binding allows the formation of intracellular 
protein complexes that signal to determine specific cellular outcomes in response to different 
environmental cues. A more detailed knowledge of how MSCs sense the mechanical, 
compositional and topological features of the ECM via integrins and their associated proteins 
will aid our understanding of the regulation of MSC growth and differentiation, and in turn will 
benefit clinical applications of these cells. 
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Abstract 
Purpose: Multipotent mesenchymal stem cells (MSCs) have the capability to differentiate 
down adipocyte, osteocyte and chondrocyte lineages and as such offer a range of potential 
therapeutic applications. The composition and stiffness of the extracellular matrix (ECM) 
environment that surrounds cells dictates their transcriptional programme, thereby affecting 
stem cell lineage decision-making. Cells sense force via linkages between themselves and 
their microenvironment, and this is transmitted by integrin receptors and associated 
adhesion signalling complexes. To identify regulators of MSC force-sensing, we sought to 
catalogue MSC integrin-associated adhesion complex composition. 
Experimental design: Adhesion complexes formed by MSCs plated on the ECM ligand 
fibronectin were isolated and characterised by mass spectrometry. Identified proteins were 
interrogated by comparison to a literature-based reference set of cell adhesion-related 
components and using ontological and protein-protein interaction network analyses. 
Results: Adhesion complex-specific proteins in MSCs were identified that consisted 
predominantly of cell adhesion-related adaptors and actin cytoskeleton regulators. 
Furthermore, LIM domain-containing proteins in MSC adhesion complexes were highlighted, 
which may act as force-sensing components. 
Conclusions and clinical relevance: These data provide a valuable resource of 
information regarding the molecular connections that link integrins and adhesion signalling in 
MSCs, and as such may present novel opportunities for therapeutic intervention. 
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Text 
Multipotent mesenchymal stem cells (MSCs) have the capacity to differentiate into multiple 
mesenchymal lineages [1] and to provide beneficial immunomodulatory factors. As such 
MSCs have attracted much attention with respect to their potential as therapeutic agents for 
tissue engineering and regenerative medicine applications [2, 3]. Many tissues and cell types 
have been demonstrated to respond to the stiffness of their local extracellular matrix (ECM) 
environments by means of mechanosensitive signalling pathways that act via transcriptional 
reprogramming to impact on normal development, wound healing and diseases such as 
fibrotic disorders [4, 5]. The extracellular environment is also a key driver of MSC 
differentiation, which is regulated by both the composition and the mechanical properties of 
the ECM that surrounds cells and tissues [6-8]. The mechanosensitive regulation of MSC 
cell fate is transmitted through RhoA and ROCK to the actin cytoskeleton, which controls the 
nuclear and cytoplasmic localisation of the transcriptional co-activators YAP and TAZ to 
regulate gene expression, resulting in MSC differentiation. In this way, ECM stiffness 
dictates MSC differentiation with stiff (bone-like) substrates tending to induce osteoblasts, 
intermediate stiffness substrates leading to myoblasts and soft substrates leading to neurons 
or adipocytes [9, 10]. 
 
Integrins are a family of cell-surface ECM receptors that mediate signalling across the 
plasma membrane from the extracellular environment to the actin cytoskeleton [11]. Integrin-
ECM engagement nucleates the formation of a dynamic, intracellular, membrane-proximal 
complex of proteins that links the ECM to the actin cytoskeleton [12]. Integrins and their 
associated adhesion complex components (the composition of which has been termed the 
adhesome) are therefore ideally placed to relay mechanosensitive cell fate decisions in a 
variety of cell types including MSCs [13, 14]. We hypothesised that a detailed understanding 
of the composition of adhesion complexes formed in MSCs upon integrin-ECM ligation would 
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improve our understanding of how the ECM and mechanosensitive signalling platforms are 
established and orchestrate cell fate decision making. We therefore isolated adhesion 
complexes from MSCs and catalogued their components by LC-MS/MS using recently 
described approaches [15-18]. The information gained from our approach will benefit 
regenerative medicine and tissue engineering approaches that use MSCs. 
 
Adhesion complex formation in human bone marrow-derived MSCs (Lonza Bioscience) 
spread on fibronectin (FN) was confirmed by immunofluorescence staining for the well-
defined adhesion complex components vinculin, integrin-linked kinase (ILK) and active 
integrin β1 (Fig. 1A). Dishes coated with poly-D-Lysine (PDL) were used as a control 
substrate that allowed cell spreading but did not support engagement of integrin and the 
formation of integrin-associated adhesion complexes (Fig. 1A). Adhesion complexes were 
then isolated from MSCs spread on FN and PDL using a published method (Fig. 1B) [18]. 
Western blotting of isolated complexes confirmed the specific recruitment of the integrin 
subunits β1 and α5, along with talin, a well characterised integrin-binding cytoskeletal 
adaptor protein [14] (Fig. 1C) in cells spread on FN compared to those on PDL. These data 
demonstrated that MSCs formed adhesion complexes upon adhesion to FN which were 
amenable to isolation by published biochemical approaches. 
 
For proteomic analysis of integrin-associated complexes, MSCs were spread on FN and the 
control ligand PDL and the isolation procedure performed in triplicate. Samples were 
analysed by LC-MS/MS. In total, from all conditions, MS analyses identified 1352 proteins 
with a FDR < 0.01% and a minimum of two unique peptides per protein (Supplementary 
Data). Using spectral counts as a measure of protein abundance, and a subtractive 
approach utilising control PDL isolations, 475 proteins were classified as specifically 
enriched to protein complexes isolated from cells spread on FN over PDL (≥2-fold FN:PDL 
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normalised spectral count ratios; Supplementary Data). Further analysis of the dataset 
highlighted 82 proteins as statistically enriched to FN compared to PDL (FDR<0.05%), 
including the integrin α5 and β1 subunits along with several well-characterised adhesion 
complex components (Supplementary Data). The current literature-curated adhesome 
inventory reported 232 proteins [12] and our analyses identified 74 of these proteins (32%) 
from all conditions (Fig. 1D; Supplementary Data) [12]. Adhesome components have been 
characterised as either intrinsic components, which localise directly to adhesion complexes, 
or associated components, which are effectors of intrinsic molecules [19]. Importantly, 47 of 
the 74 adhesome proteins (38 intrinsic and 10 associated components, respectively; 
Supplementary Data) were determined to be enriched to complexes isolated from cells 
spread on FN compared to PDL, a comparable number to previous analyses of this kind [20, 
21]. Therefore, these data reveal the subset of the adhesome that is found in adhesion 
complexes in MSCs. To gain an unbiased, global perspective of the dataset, Gene Ontology 
(GO) enrichment analysis was performed on FN-enriched proteins using the online 
bioinformatic tools available via the Database for Annotation, Visualization and Integrated 
Discovery (DAVID; http://david.abcc.ncifcrf.gov/home.jsp) [22]. These analyses confirmed 
that proteins identified using this approach were enriched for terms relating to cell-substrate 
junctions, cell adhesion, cell migration and connections to the actin cytoskeleton, as 
expected for adhesion complex proteins (Supplementary Data). 
 
To provide a simplified view of the molecular organisation of the isolated adhesion 
complexes in the context of known adhesion complex protein interactions, a network was 
constructed using the identified MSC adhesome components and organised according to 
their defined roles (Fig. 2) [19]. This analysis highlighted that, while adhesome proteins were 
identified from a wide variety of functional groups, from an adhesome-based perspective, the 
majority of FN-enriched proteins were identified from the adaptor and actin regulator 
subgroups of the adhesome. Importantly, as for adhesion complexes from other cell types 
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and potentially relating to cell fate determination, these findings are indicative of MSC 
adhesion complexes performing the dual roles of establishing connections to the actin 
cytoskeleton and acting to nucleate adaptor proteins as signalling hubs. In addition, MS 
analysis of isolated MSC adhesion complexes identified only a restricted set of integrin FN 
receptors that were enriched to FN compared to the control PDL (Fig. 2). To assess the 
repertoire of integrins on the cell surface of MSCs, flow cytometry was performed. In 
agreement with previous studies [23], these analyses revealed that MSCs express a number 
of integrin heterodimers that can bind a variety of ECM ligands [24], including FN (α5β1, 
αVβ1 and αVβ3), collagen (α1β1 and α2β1) and laminin (α3β1 and α6β1) (data not shown). 
Investigation of the numbers of peptides identified for each integrin subunit revealed that the 
major integrin identified by MS in MSC adhesion complexes was α5β1 (Supplementary 
Data). Therefore, these data indicate that, under the conditions assessed, MSCs primarily 
utilise α5β1 to engage FN, and therefore the associated protein identifications in this study 
are likely to be from adhesion complexes predominantly formed by integrin α5β1. 
 
Previous MS analyses of adhesion complexes isolated from fibroblasts have established that 
the LIN-11, Isl1, and MEC-3 (LIM) domain-containing proteins are recruited to adhesion 
complexes via forces generated by the myosin II contractile machinery [15, 16]. Similar 
forces have been shown to regulate the ECM elasticity-dependent control of MSC cell fate 
via YAP/TAZ [9]. Interestingly, GO enrichment analysis of proteins identified by MS from 
MSC adhesion complexes demonstrated a significant enrichment of LIM domain-containing 
proteins (Supplementary Data), as previously observed for adhesion complexes isolated 
from fibroblasts [15, 16]. In total, 24 LIM domain proteins were identified in the dataset, 21 of 
which were at least two-fold enriched to FN (Supplementary Data). Visualisation of the 
identified LIM domain proteins in the context of their known interactions with proteins from 
the adhesome highlighted the potential interplay between LIM domain proteins in MSC 
adhesion complexes and the adhesome (Fig. 3A). As some LIM domain proteins convey 
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mechanosensitive signals through adhesion complexes to the actin cytoskeleton [25, 26], we 
hypothesised that the LIM domain proteins identified in MSCs in this study may play roles in 
MSC cell fate determination and localise at different cellular locations in response to altered 
ECM stiffness. We therefore investigated the mechanosensitive localisation of PDLIM1, 
PDLIM5 and PDLIM7, which are LIM domain proteins identified in this study that are not 
currently categorised as adhesome components. MSC cells spread on a stiff substrate 
(glass) coated with FN formed prominent vinculin-positive adhesion complex structures, a 
subset of which colocalised with, or closely to, clusters of PDLIM1 or PDLIM5 (Fig. 3B). 
Interestingly, PDLIM1, PDLIM5 and PDLIM7 displayed distinct subcellular localisation 
patterns in MSCs. For example, PDLIM7 localised away from the leading edge of cells, 
unlike PDLIM1 and PDLIM5. Moreover, MSCs spread on a soft substrate (12 kPa; Matrigen) 
formed fewer vinculin-positive adhesion structures and displayed an altered localisation of 
PDLIM1, PDLIM5 and PDLIM7 (Fig. 3B). Importantly, the substrate elasticity used for these 
studies was in the range that resulted in a nuclear-cytoplasmic redistribution of YAP/TAZ 
(data not shown). In brief, cells spread on glass or 12 kPa stiffness demonstrated nuclear 
YAP/TAZ, whereas cells on 0.5 kPa stiffness displayed cytoplasmic retention of YAP/TAZ, 
smaller spreading areas and did not form vinculin-positive adhesion complexes. These data 
highlight that proteins identified from the MSC adhesion complex dataset, such as PDLIM1, 
PDLIM5 and PDLIM7, can display tension-dependent relocalisation within cells and indicate 
that the dataset may be of benefit for future study by the wider research community. 
 
In summary, we have enriched and isolated adhesion complex structures from MSCs spread 
on FN and catalogued their composition by LC-MS/MS, revealing a subset of adhesome 
proteins found in MSCs that contained many potentially mechanoresponsive LIM domain-
containing proteins. Application of MSCs to cell therapy or tissue engineering requires an 
understanding of how to maintain and differentiate MSCs both in vitro and in vivo [27, 28]. 
Moreover, ECM elasticity, ECM composition, integrins and their associated adhesion 
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complex components are now widely appreciated to play roles in MSC growth, differentiation 
and homing [14, 29-31]. FN is a component of the ECM that has been shown to regulate 
stem biology in a variety of systems including MSC cell fate decisions [32-35]. Therefore, we 
suggest that the proteins identified in the present study will inform strategies to utilise MSCs 
in basic science and for therapeutic applications. Future studies could be directed to further 
strengthen such findings by repeating these analyses and performing comparison of 
adhesion complex isolations from MSCs on soft versus stiff ECM substrates. 
 
 
Acknowledgements 
We thank S. Warwood and E. Keevill for MS support, J. N. Selley for bioinformatic support, 
P. March for microscopy support and the PRIDE team for assistance with MS data 
deposition. We thank T. E. Hardingham and K. E. Kadler for advice regarding growth of 
MSCs, D. Vestweber for provision of antibody 9EG7 and J. A. Wilkins for provision of 
antibody JB1A. This work was supported by the Wellcome Trust (grant 092015 to M.J.H.), 
the Biotechnology and Biological Sciences Research Council (BBSRC) (grant BB/D014638/1 
to S. J. K.), a grant from the Northwest Regional Development Agency (to S. J. K.), a 
Wellcome Trust Institutional Strategic Support Fund award (grant 097820 to the University of 
Manchester) and a Postdoctoral Fellowship Becas Chile award (74140039 to P.A.). E.R.H is 
supported by a BBSRC studentship as part of the Systems Biology Doctoral Training Centre. 
The mass spectrometers and microscopes used in this study were purchased with grants 
from the BBSRC, Wellcome Trust and the University of Manchester Strategic Fund. The MS 
data have been deposited to the ProteomeXchange Consortium [36] 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository 
(http://www.ebi.ac.uk/pride) with the dataset identifier PXD001809 (DOI: 
10.6019/PXD001809). 
www.clinical.proteomics-journal.com Page 10 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
References 
[1] Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K. et al., Multilineage Potential of 
Adult Human Mesenchymal Stem Cells. Science 1999, 284, 143-147. 
[2] Caplan, A. P. Adult mesenchymal stem cells for tissue engineering versus regenerative 
medicine. J Cell. Physiol. 2007, 213, 341-7 
[3] Keating, A. Mesenchymal stromal cells: new directions. Cell Stem Cell 2012 10, 709,716. 
[4] Tschumperlin, D. J., Liu, F., Tager, A. M. Biomechanical regulation of mesenchymal cell 
function. Curr. Opin. Rheumatol. 2013, 25, 92-100. 
[5] Mammoto, T., Mammoto, A., Ingber, D. E. Mechanobiology and Developmental Control. 
Annu. Rev. Cell Dev. Biol. 2013, 29, 27-61. 
[6] Engler, A. J., Sen, S., Sweeney, H. L., Discher D. E. Matrix elasticity directs stem cell 
lineage specification Cell 2006 126, 677-89. 
[7] Reilly, G. C., Engler, A. J. Intrinsic extracellular matrix properties regulate stem cell 
differentiation. J. Biomech. 2010, 43, 55-62. 
[8] Bellas, E., Chen, C. S. Forms, forces, and stem cell fate. Curr. Opin. Cell Biol. 2014, 31, 
92-97. 
[9] Dupont, S., Morsut, L., Aragona, M., Enzo, E., et al., Role of YAP/TAZ in 
mechanotransduction. Nature 2011, 474, 179-183. 
[10] Halder, G., Dupont. S., Piccolo, S. Transduction of mechanical and cytoskeletal cues by 
YAP and TAZ. Nat. Rev. Mol. Cell Biol. 2012, 13, 591-600. 
[11] Wolfenson, H., Lavelin, I., Geiger, B. Dynamic regulation of the structure and functions 
of integrin adhesions. Dev. Cell 2013 24, 447-458. 
www.clinical.proteomics-journal.com Page 11 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
[12] Winograd-Katz, S. E., Fässler, R., Geiger, B., Legate, K. R. The integrin adhesome: 
from genes and proteins to human disease. Nat. Rev. Mol. Cell Biol. 2014 15, 273-288. 
[13] Maartens, A. P., Brown, N. H. Anchors and Signals: The Diverse Roles of Integrins in 
Development. Curr. Top. Dev. Biol. 2015, 112, 233-272. 
[14] Mathieu, P.S., Loboa, E. G. Cytoskeletal and focal adhesion influences on 
mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, 
adipogenic, and chondrogenic pathways. Tissue Eng. Part B Rev. 2012, 18, 436-44. 
[15] Kuo, J-C., Han, X., Hsiao, C-T., Yates III, J. R., Waterman C. M. Analysis of the myosin-
II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal 
adhesion maturation. Nat. Cell Biol. 2011, 13, 383–393. 
[16] Schiller, H. B., Friedel, C. C., Boulegue, C., Fässler, R. Quantitative proteomics of the 
integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins. EMBO 
Rep. 2011, 12, 259–266. 
[17] Byron, A., Askari, J. A., Humphries, J. D., Jacquemet, G., A proteomic approach reveals 
integrin activation state-dependent control of microtubule cortical targeting. Nat. Commun. 
2015, 6, 6135. 
[18] Jones, M. C., Humphries, J. D., Byron, A., Millon-Frémillon, A., Isolation of integrin-
based adhesion complexes. Curr. Protoc. Cell Biol. 2015, 66, 9.8.1-9.8.15. 
[19] Zaidel-Bar, R., Itzkovitz, S., Ma’ayan, A., Iyengar, R., Geiger, B. Functional atlas of the 
integrin adhesome. Nat. Cell Biol. 2007, 9, 858–867. 
[20] Geiger, T., Zaidel-Bar, R. Opening the floodgates: proteomics and the integrin 
adhesome. Curr. Opin. Cell Biol. 2012, 24, 562–568. 
www.clinical.proteomics-journal.com Page 12 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
[21] Humphries, J. D., Paul, N. R., Humphries, M. J., Morgan, M. R. Emerging properties of 
adhesion complexes: What are they and what do they do? Trends Cell Biol. 2015 In press 
DOI 10.1016/j.tcb.2015.02.008 
[22] Huang, D. W., Sherman, B. T., Lempicki, R. A. Systematic and integrative analysis of 
large gene list using DAVID Bioinformatics. Nat. Protoc. 2009, 4, 44–57. 
[23] Frith, J. E., Mills, R. J., Hudson, J. E., Cooper-White J. J. Tailored integrin-extracellular 
matrix interactions to direct human mesenchymal stem cell differentiation. Stem Cells Dev. 
2012, 21, 2442-56. 
[24] Humphries, J. D., Byron, A., Humphries, M. J. Integrin ligands at a glance. J. Cell Sci. 
2006, 119, 3901-3903. 
[25] Schiller, H. B., Fässler, R. Mechanosensitivity and compositional dynamics of cell-matrix 
adhesions. EMBO Rep. 2013, 14, 509-519. 
[26] Smith, M. A., Hoffman, L. M., Beckerle, M. C. LIM proteins in actin cytoskeleton 
mechanoresponse. Trends Cell Biol. 2014, 24, 575-583. 
[27] Wang, Y-K., Chen, C. S. Cell adhesion and mechanical stimulation in the regulation of 
mesenchymal stem cell differentiation. J. Cell. Mol. Med. 2013, 17, 823-832. 
[28] Bara, J. J., Richards, R. G., Alini, M., Stoddart, M. J. Bone Marrow-Derived 
Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for 
Basic Research and the Clinic. Stem Cells 2014, 32, 1713-1723. 
[29] Kaneko, K., Ito, M., Naoe, Y,. Lacy-Hulbert, A., Ikeda, K. Integrin αv in the mechanical 
response of osteoblast lineage cells. Biochem Biophys Res Commun. 2014, 447, 352-7. 
[30] Marie, P. J. Targeting integrins to promote bone formation and repair. Nat. Rev. 
Endocrinol. 2013, 9, 288-295. 
www.clinical.proteomics-journal.com Page 13 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
[31] Huang, I. H., Hsiao, C. T., Wu, J. C., Shen, R. F. et al., GEF-H1 controls focal adhesion 
signaling that regulates mesenchymal stem cell lineage commitment. 2014 J. Cell Sci. 127, 
4186-4200. 
[32] Adams, J. C., Watt, F. M. Fibronectin inhibits the terminal differentiation of human 
keratinocytes. Nature 1989, 340, 307-309. 
[33] Baxter, M. A., Camarasa, M. V., Bates, N., Small, F., et al., Analysis of the distinct 
functions of growth factors and tissue culture substrates necessary for the long-term self-
renewal of human embryonic stem cell lines. Stem Cell Res. 2009, 3, 28-38. 
[34] Singh, P., Schwarzbauer, J. E. Fibronectin and stem cell differentiation - lessons from 
chondrogenesis. J. Cell Sci. 2012, 125, 3703-12. 
[35] Martino, M. M., Mochizuki, M., Rothenfluh, D. A., Rempel, S. A. et al., Controlling 
integrin specificity and stem cell differentiation in 2D and 3D environments through 
regulation of fibronectin domain stability. Biomaterials 2009, 30, 1089-97. 
 
[36] Vizcaíno, J. A., Deutsch, E. W., Wang, R., Csordas, A., et al., ProteomeXchange 
provides globally co-ordinated proteomics data submission and dissemination. Nature 
Biotechnol. 2014, 30, 223-226. 
[37] Choi, H., Fermin, D. Nesvizhskii, A. I. Significance analysis of spectral count data in 
label-free shotgun proteomics. Mol. Cell. Proteomics 2008, 7, 2373–2385. 
 
Conflict of Interest Statement 
The authors have declared no conflict of interest 
 
 
www.clinical.proteomics-journal.com Page 14 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
  
www.clinical.proteomics-journal.com Page 15 Proteomics - Clinical Applications 
 
This article is protected by copyright. All rights reserved. 
 
Figure 1 Isolation and proteomic analysis of adhesion complexes from MSCs. 
Human bone marrow-derived MSCs obtained from a 22-year-old female donor (Lonza 
BioScience) were isolated from human tissue with informed consent and were validated for 
the positive expression of CD105, CD166, CD29 and CD44 and for the negative expression 
of CD14, CD34 and CD45 by the supplier. Independent validation of positive expression of 
CD105 and negative expression of CD14 was performed by flow cytometry before use (data 
not shown). (A) Immunofluorescence images of MSCs spread on 10 µg/ml FN or PDL 
(Sigma-Aldrich) for 3 hours, fixed with 4% (w/v) paraformaldehyde, permeabilised with 
0.05% (w/v) Triton X-100 and visualised with antibodies directed against vinculin (hVIN-1; 
Sigma-Aldrich), ILK (clone; Abcam) or active β1 integrin (9EG7; provided by D. Vestweber, 
Max Planck Institute for Molecular Biomedicine, Germany). Images were collected on an 
Olympus BX51 upright microscope using a 20×/0.50 Plan Fln objective, captured using a 
Coolsnap HQ camera (Photometrics) through MetaVue software (Molecular Devices) and 
processed using ImageJ (http://rsb.info.nih.gov/ij).  (B) Workflow of adhesion complex 
isolation and MS analysis. The analyses were performed in biological triplicate on either 
Orbitrap elite or Velos Pro systems (Thermo Fisher Scientific). (C) Adhesion complexes 
isolated from MSCs were subjected to SDS-PAGE and western blotting for β1 integrin 
(JB1A; provided by J. A. Wilkins, University of Manitoba, Canada), α5 integrin (H-104; Santa 
Cruz Biotechnology) or talin (C-20; Santa Cruz Biotechnology). (D) Volcano plot displaying 
all proteins (black circles) or adhesome proteins (red circles) identified by MS from adhesion 
complexes isolated from MSCs. Statistics were determined by QSpec analysis 
(http://www.nesvilab.org/qspec.php/; [37]). Values for FDR(-log10) of 7 represent calculated 
FDR values of 0 in Qspec. 
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Figure 2 Protein-protein interaction network of adhesome components identified in MSC 
cells. Interaction network analysis of adhesome components isolated from FN or PDL-
induced adhesion complexes. Nodes (circles) represent identified proteins and are labelled 
with gene symbols, arranged according to their reported functional group [29] and coloured 
with respect to their enrichment to FN or PDL as defined by their normalised spectral count 
ratios. Edges (grey lines) indicate reported protein-protein interactions. Interaction network 
analysis was performed as previously described [25] using Cytoscape (version 2.8.3) and a 
merged human interactome consisting of protein-protein interactions reported in the Protein 
Interaction Network Analysis platform, MatrixDB and the adhesome. Of the 232 adhesome 
components, 74 were detected in the dataset and 48 of these were enriched ≥2-fold to FN 
compared to PDL. PLEC and NRP1 did not map on to the interaction network database. 
GEF, guanine nucleotide exchange factor; GAP, GTPase-activating protein. 
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Figure 3 LIM domain proteins identified in adhesion complexes from MSCs. 
 (A) Protein interaction network of all LIM proteins identified by MS and proteins with which 
they reportedly directly interact in the adhesome. (B) Immunofluorescence images of MSCs 
spread on glass or polyacrylamide-coated coverslips with defined stiffness (12 kPa, 
Matrigen) previously coated with FN (20 μg/ml). MSCs were cultured for 24 hours before 
fixation with 4% (w/v) paraformaldehyde and visualised using antibodies against PDLIM1 
(ab64971, Abcam), PDLIM5 (E-25 and JK-3R, Santa Cruz Biotechnology) and PDLIM7 
(ab86065, Abcam), and vinculin (hVIN-1; Sigma-Aldrich). Confocal microscopy images were 
collected on a Leica TCS SP5 AOBS upright confocal using a 20×/0.50 HCX Apo L water 
objective and processed using ImageJ. 
 
 
 
